Okyo Pharma
Okyo Pharma Logo
About Okyo Pharma
OKYO Pharma Ltd is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for inflammatory eye diseases and ocular pain. Its lead candidate, Urcosimod (OK-101), targets dry eye disease and neuropathic corneal pain, with additional programs for allergic conjunctivitis, uveitis, and chronic pain. OKYO Pharma aims to address unmet medical needs in ophthalmology, with clinical and preclinical programs advancing innovative treatments for patients worldwide.
Address
14/15 Conduit St, Floor 4
London, W1S 2XJ
United Kingdom
Year founded
2018
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
